What is the Impact Factor of Experimental and Clinical Psychopharmacology?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Experimental and Clinical Psychopharmacology is 1.60, ranking in quartile Q4 of Web of Science (SCIE).

Is Experimental and Clinical Psychopharmacology indexed in Web of Science or Scopus?

Yes, Experimental and Clinical Psychopharmacology is indexed in Web of Science (SCIE, Q4 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.796 (Q2) and an H-index of 105.

Who publishes Experimental and Clinical Psychopharmacology and what is the Article Processing Charge (APC)?

Experimental and Clinical Psychopharmacology is published by American Psychological Association Inc.. The estimated Article Processing Charge (APC) is approximately $3,224 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Experimental and Clinical Psychopharmacology?

The official ISO-4 abbreviation of Experimental and Clinical Psychopharmacology is "Exp. Clin. Psychopharmacol" with common acronym "pha". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q4Scopus Q2SCImago #6,969Hybrid

Experimental and Clinical Psychopharmacology

Acronym:pha

•

Abbreviation (ISO):Exp. Clin. Psychopharmacol

•

Identifier (ISSN):1064-1297(Print)/1936-2293(Online)

•

Publisher:American Psychological Association Inc.

Official Website Submission Portal Compare

Clarivate IF (2026)

1.6↓ -0.6

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Experimental and Clinical Psychopharmacology

WoS Q4

Annual Impact Factor Metric

Current (2026):1.6

Scopus SJR & RankScopus Q2

0.796

#6,969

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

105

105 papers with at least that number of citations each

WoS: SCIE / JCRQ4

Self-Citation Rate8.3%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

142articles/year

67.03% Gold OA•92.66% Original Research

Aims & Scope

Experimental and Clinical Psychopharmacology publishes advances in translational and interdisciplinary research on psychopharmacology, broadly defined, and/or substance abuse.

Topics Covered (Recognized by AI)

Psychology97.8%Medicine96.4%Biology85.9%Psychiatry78.1%Internal medicine59.2%Neuroscience53.6%Chemistry49.3%Biochemistry45.1%Clinical psychology44.6%Pharmacology37%Pathology30.9%Anesthesia27.8%Political science26.4%Social psychology26.4%Philosophy26.3%Law26.2%Psychotherapist25.1%Genetics23.6%Endocrinology23.2%Developmental psychology22.8%Computer science21.7%Economics21.6%Organic chemistry21%

Primary Research Areas

Medicine Psychiatry

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

PHARMACOLOGY & PHARMACY

Rank276/356

IndexSCIE

JCRSCIE2026

PSYCHIATRY

Rank213/293

IndexSCIE

JCRSSCI2026

PSYCHOLOGY, BIOLOGICAL

Rank11/17

IndexSSCI

JCRSSCI2026

PSYCHOLOGY, CLINICAL

Rank115/184

IndexSSCI

JCISCIE2026

PHARMACOLOGY & PHARMACY

Rank172/356

IndexSCIE

JCISCIE2026

PSYCHIATRY

Rank165/293

IndexSCIE

JCISSCI2026

PSYCHOLOGY, BIOLOGICAL

Rank9/17

IndexSSCI

JCISSCI2026

PSYCHOLOGY, CLINICAL

Rank109/184

IndexSSCI

Category	Index	Rank	Quartile
PHARMACOLOGY & PHARMACY	JCRSCIE	276/356	Q4
PSYCHIATRY	JCRSCIE	213/293	Q3
PSYCHOLOGY, BIOLOGICAL	JCRSSCI	11/17	Q3
PSYCHOLOGY, CLINICAL	JCRSSCI	115/184	Q3
PHARMACOLOGY & PHARMACY	JCISCIE	172/356	Q2
PSYCHIATRY	JCISCIE	165/293	Q3
PSYCHOLOGY, BIOLOGICAL	JCISSCI	9/17	Q3
PSYCHOLOGY, CLINICAL	JCISSCI	109/184	Q3

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF1.6

Articles / Year60

Total Citations1

2025

IF2.2

Articles / Year88

Total Citations46

2024

IF2.4

Articles / Year86

Total Citations123

2023

IF2.3

Articles / Year106

Total Citations427

2022

IF3.492

Articles / Year135

Total Citations973

Year	Impact Factor	Articles / Year	Total Citations
2026	1.6	60	1
2025	2.2	88	46
2024	2.4	86	123
2023	2.3	106	427
2022	3.492	135	973
2021	3.157	140	1,438
2020	2.217	96	1,219
2019	1.922	121	1,756
2018	2.354	108	1,935
2017	—	70	1,382
2016	—	46	1,015
2015	—	67	3,007

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #6,969Scopus Q2SCImago Profile

Scopus Coverage:1993-2026

•

Scopus Broad Areas:MedicinePharmacology, Toxicology and Pharmaceutics

Scopus Citation Rank (SJR)Q2

0.796

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2

Citations / Doc (2 years)

1.76

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,224 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations555

3-Year Documents235

Citable Documents232

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate54.9%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

PharmacologyQ2

Pharmacology (medical)Q2

Psychiatry and Mental HealthQ2

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 8.3%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

3区 (Zone 3)Medicine

Minor Category (Specific Field):

3区PSYCHOLOGY, BIOLOGICAL

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Experimental and Clinical Psychopharmacology (acronym: pha, abbr: Exp. Clin. Psychopharmacol, ISSN: 1064-1297) is a peer-reviewed international scholarly journal in the field of Medicine, published by American Psychological Association Inc. in United States since 1993. The periodical holds a Journal Impact Factor (JIF) of 1.60, ranking in quartile Q4 of Web of Science (SCIE), a Scopus SJR indicator of 0.796 (Q2), an H-index of 105.

The journal enforces rigorous peer evaluation with a publication frequency of Quarterly, an annual output of approximately 142 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,224 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.